Insulet Collaborates with Samsung to Deliver Galaxy Smartphone-Controlled Insulin Pump Delivery System

Insulet Corporation, the global leader in tubeless insulin pumptechnology with its Omnipod® Insulin Management System (Omnipod System), today announced it is collaborating with Samsung Electronics America, Inc. for a Samsung Galaxy smartphone-controlled Omnipod System. Once approved, the system will be the first device providing consumers the ability to use their personal Galaxy smartphone1 to securely control their insulin pump therapy.

Please to read the entire article.

You must be logged in to post a comment Login